Skip to main content
. Author manuscript; available in PMC: 2024 Jul 12.
Published in final edited form as: Cell Rep. 2024 Jun 11;43(6):114330. doi: 10.1016/j.celrep.2024.114330

Figure 6. Removal of CGG repeats from the FMR1 5’ UTR affects GR subcellular localization after DEX treatment.

Figure 6.

(A) Schematic showing the timing of DEX treatment in hESC-derived neurons.

(B) qRT-PCR data showing NR3C1 mRNA levels in H13 and H13–0CGG neurons. n = 3 independent differentiations. Error bars indicate SEM.

(C) GR protein levels in DEX-treated hESC-derived neurons. (Left) Representative western blot images from H1 and H13 neurons. (Right) Quantification of GR protein levels. n = 5–6 independent batches of differentiation from N = 2 cell lines. Data shown are normalized to 31 CGG-VEH condition. Error bars indicate SEM.

(D) Schematic showing the timing of acute DEX treatment of hESC-derived neurons.

(E) Representative confocal images of the GR receptor expression in MAP2+ neurons. Scale bars, 5 μm. Arrowheads demonstrate differences in soma GR signal in DEX-treated 31CGG and 0CGG neurons. Magenta, GR; green, MAP2 (postmitotic neuron marker); blue, nuclear staining using Hoechst.

(F and G) Quantification of GR fluorescent signal in nucleus (F) and soma (G). n = 111–125 individual neurons from N = 2 cell lines. (B and C) Two-way ANOVA. (F) Brown-Forsythe and Welch ANOVA test followed by Games-Howell’s multiple comparison’s test, ****p < 0.001. (G) One-way ANOVA followed by Tukey’s multiple comparison’s test, *p < 0.05.